MRK dividend yield: 3.25%. XOM dividend yield: 3.58%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. ExxonMobil is a Dividend Aristocrat with 42+ consecutive years of dividend increases. The world's largest publicly traded oil company benefits from integrated operations across upstream, downstream, and chemicals. Its acquisition of Pioneer Natural Resources in 2024 significantly expanded its low-cost Permian Basin production.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
ExxonMobil is a Dividend Aristocrat with 42+ consecutive years of dividend increases. The world's largest publicly traded oil company benefits from integrated operations across upstream, downstream, and chemicals. Its acquisition of Pioneer Natural Resources in 2024 significantly expanded its low-cost Permian Basin production.
MRK currently offers a 3.25% yield (3.08/share/year) while XOM offers 3.58% (3.88/share/year). XOM provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs XOM earn per year?
With $10,000 invested today: MRK pays approximately $325/year. XOM pays approximately $358/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $617/year (XOM).
Does MRK or XOM pay monthly dividends?
MRK pays quarterly dividends. XOM pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs XOM comparison by email
Save your analysis + get weekly dividend insights. Free forever.